SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page1516171819202122Next Page
2026-09-09EDIT3Power of Attorney for Section 16 Reporting ObligationsMEDIUM
This filing is a power of attorney granted by Daniel Ory, M.D., EVP, Chief Medical Officer of Editas Medicine, Inc., to Gilmore O’Neill, Damien Grierson, and Amy Parison. The purpose of this power of attorney is to authorize these individuals to execute and file Section 16 reports (Forms 3, 4, and 5) with the SEC on be...
Small CapBiotechnology
2026-09-09CYBN3Form 3 Filing for CYBIN INC. - Initial Statement of Beneficial Ownership
This filing is an initial statement of beneficial ownership for Eric H. L. So, Executive Chair of CYBIN INC. The filing is voluntary as Mr. So is not subject to Section 16 reporting requirements. Mr. So directly holds 4,170,014 common shares and indirectly holds an additional 53,616 common shares through his spouse. Ad...
Biotechnology
Previous Page1516171819202122Next Page